Separate findings from REMAP-CAP showed last week that treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improved survival rates
Punjab Health Care Commission on Monday banned plasma transfusions to coronavirus patients without prior permission from coronavirus expert advisory group
France is to begin clinical trials involving transfusions of blood plasma from coronavirus survivors into patients who have severe symptoms in a bid to treat the illness.